SPONSOR
Johann Wolfgang Goethe University Hospital
Total Trials
2
Recruiting
2
Phases
Phase 1
Conditions studied: GlioblastomaMyocarditisHeart FailureMyocardial FibrosisVascular InflammationLong COVID Syndrome
Johann Wolfgang Goethe University Hospital is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Glioblastoma, Myocarditis, Heart Failure, Myocardial Fibrosis.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Johann Wolfgang Goethe University Hospital
How many clinical trials has Johann Wolfgang Goethe University Hospital sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Johann Wolfgang Goethe University Hospital, of which 2 are actively recruiting participants. These trials cover conditions including Glioblastoma, Myocarditis, Heart Failure. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Johann Wolfgang Goethe University Hospital research focus on?
Johann Wolfgang Goethe University Hospital clinical trials span Glioblastoma, Myocarditis, Heart Failure, Myocardial Fibrosis, Vascular Inflammation, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Johann Wolfgang Goethe University Hospital clinical trial?
To participate in a Johann Wolfgang Goethe University Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Johann Wolfgang Goethe University Hospital trials with current recruitment status updated daily.
Clinical Trials by Johann Wolfgang Goethe University Hospital
NCT03383978 Phase 1
Recruiting
Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma
Glioblastoma
NCT04444128
Recruiting
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
Myocarditis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology